Last reviewed · How we verify
NCT06886178: STIL-PD
Effectiveness of STIL Orthosis in PD
NA trial testing STIL Orthosis in Parkinson&Amp;#39;s Disease in 25 participants. Completed in 1 December 2025.
1 December 2025
Quick facts
| Lead sponsor | Radboud University Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 19 February 2025 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- STIL Orthosis
- Sham
Conditions studied
- Parkinson&Amp;#39;s Disease — all drugs for Parkinson&Amp;#39;s Disease →
- Action Tremor — all drugs for Action Tremor →
Sponsor
Radboud University Medical Center
Who can join
18 and older, any sex, with Parkinson&Amp;#39;s Disease or Action Tremor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parkinson's disease is a neurodegenerative condition that leads to uncontrollable shaking (tremor), which can substantially impair everyday activities. The goal of this clinical trial is to learn if the STIL Orthosis works as a treatment option for tremor in people with Parkinson's disease. The main questions it aims to answer are: * Does the STIL Orthosis reduce tremor? * Are users satisfied with the usability and comfort of the STIL Orthosis? * Does the STIL Orthosis have any adverse effects? Participants' tremor will be measured during three conditions: * While wearing the STIL Orthosis * While wearing an orthosis without dampening (sham) * While wearing no orthosis (baseline) Researchers will compare the severity of tremor while wearing the STIL Orthosis against tremor during sham and baseline.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06886178
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson&Amp;#39;s Disease
Currently open trials in the same condition.
- NCT06772220 — Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease · NA · recruiting
Other Radboud University Medical Center trials
Trials by the same sponsor.
- NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
- NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
- NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
- NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
- NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06886178 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
- Last refreshed: 19 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06886178.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing